Health Care Equipment

CUTERA INC

Cutera, Inc. truFlex Muscle Stimulating Technology Approved for New Indications

CUTERA INC released FY2024 9 Months Earnings on November 12 After-Market (EST), with actual revenue of 105.67 M USD and EPS of -4.31 USD

CUTERA INC released FY2023 9 Months Earnings on November 12 After-Market (EST), with actual revenue of 162.83 M USD and EPS of -5.3212 USD

CUTERA INC released FY2024 Q3 earnings on November 12 After-Market EST, actual revenue 32.5 M USD (forecast 32.04 M USD), actual EPS -1.94 USD

CUTERA INC released FY2023 Q3 earnings on November 12 After-Market EST, actual revenue 46.48 M USD (forecast 48.83 M USD), actual EPS -2.2212 USD

CUTERA INC released FY2024 Q2 earnings on August 9 After-Market (EST), actual revenue 34.38 M USD (forecast 38.69 M USD), actual EPS -1.23 USD

CUTERA INC released FY2023 Q2 earnings on August 9 After-Market (EST), actual revenue 61.83 M USD (forecast 64.93 M USD), actual EPS -1.68 USD

CUTERA INC released FY2023 Semi-Annual Earnings on August 9 After-Market (EST), with actual revenue of 116.35 M USD and EPS of -3.0943 USD

CUTERA INC released FY2024 semi-annual earnings on August 9 After-Market (EST), actual revenue 73.17 M USD, actual EPS -2.37 USD

CUTERA INC released FY2023 Q4 earnings on May 10 After-Market (EST), actual revenue 49.54 M USD (forecast 47.5 M USD), actual EPS -2.8676 USD

CUTERA INC released FY2023 Q1 earnings on May 10 After-Market (EST), actual revenue 54.53 M USD (forecast 59.8 M USD), actual EPS -1.42 USD

CUTERA INC released FY2022 Q4 earnings on May 10 After-Market (EST), actual revenue 67.35 M USD (forecast 69.52 M USD), actual EPS -0.3964 USD

CUTERA INC released FY2024 Q1 earnings on May 10 After-Market (EST), actual revenue $38.79M (forecast $37.66M), actual EPS -$1.14

CUTERA INC released FY2021 annual earnings on May 10 After-Market (EST), actual revenue 231.27 M USD (forecast 226.44 M USD), actual EPS 0.11 USD

CUTERA INC released FY2023 annual earnings on May 10 After-Market (EST), actual revenue 212.37 M USD (forecast 210.33 M USD), actual EPS -8.19 USD

CUTERA INC released FY2022 Annual Earnings on May 10 After-Market (EST), actual revenue 252.4 M USD (forecast 254.59 M USD), actual EPS -4.3921 USD

CUTERA INC released FY2022 Q1 earnings on March 5 After-Market (EST), actual revenue 58.01 M USD (forecast 57.26 M USD), actual EPS -0.84 USD

CUTERA INC released FY2022 9 Months Earnings on March 5 After-Market EST, with actual revenue of 185.05 M USD and EPS of -3.99 USD

CUTERA INC released FY2022 Q3 earnings on March 5 After-Market (EST), actual revenue 62.81 M USD (forecast 62.24 M USD), actual EPS -0.62 USD

CUTERA INC released FY2022 semi-annual earnings on March 5 After-Market EST, with actual revenue of 122.24 M USD and EPS of -3.3937 USD

Apellis Pharma

AMPLITECH GROUP INC. USD0.001 S/R 20/11/26 SER B

U-BX Tech

3 E Network Tech

PMGC

AMPLITECH GROUP INC. COM USD0.001 (S/R 18/07/2026)

Bullfrog AI

Jaguar Uranium

Texxon

Classover Holdings - Class B

Delcath

Abbott Laboratories

Intuitive Surgical

Stryker

Boston Scientific

Edwards Lifesciences

IDEXX Labs

Resmed

DexCom

Steris

Style Score

Growth Score

Revenue YoY

Net Profit YoY

Value Score

P/B Ratio

Dividend Ratio

Size Score

Market Cap Score

Market Cap

Revenue Score

Revenue

Multi Score

Profit Score

Profit Margin

Gross Margin

Total Assets YoY

Net Assets YoY

Cash Score

Cash Flow Margin

OCF YoY

Operating Score

Turnover

Debt Score

Gearing Ratio

Please note that a "Suspected value trap" is a stock that appears The stock looks financially sound and severely undervalued, but behind the low valuation is a long-term decline in business capacity or a serious financial crisis, or even the risk of bankruptcy in the short term.

Suspected value trap

CUTERA INC(CUTRQ.US)

CUTERA INC Stock Performance Chart